PUBLISHER: The Business Research Company | PRODUCT CODE: 1546395
PUBLISHER: The Business Research Company | PRODUCT CODE: 1546395
Aortic stent grafts are medical devices designed to strengthen weakened sections of the aorta, the body's primary blood vessel. They consist of a fabric tube (graft) supported by a metal mesh (stent) and are implanted using minimally invasive procedures to address conditions such as aneurysms affecting the aorta.
Abdominal aortic stent grafts and thoracic aortic stent grafts are the two main types. Abdominal aortic stent grafts specifically target abdominal aortic aneurysms by reinforcing the weakened vessel wall to prevent potential rupture. These devices find application in various settings such as hospitals, ambulatory surgical centers, and outpatient facilities for treating both abdominal and thoracic aortic aneurysms.
The aortic stent grafts market research report is one of a series of new reports from The Business Research Company that provides aortic stent grafts market statistics, including the aortic stent grafts industry's global market size, regional shares, competitors with an aortic stent grafts market share, detailed aortic stent grafts market segments, market trends and opportunities, and any further data you may need to thrive in the aortic stent grafts industry. This aortic stent grafts market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The aortic stent grafts market size has grown strongly in recent years. It will grow from $3.06 billion in 2023 to $3.32 billion in 2024 at a compound annual growth rate (CAGR) of 8.5%. Historical growth can be credited to a growing preference for minimally invasive surgeries, increasing life expectancy rates, expanded use of diagnostic imaging technologies in healthcare, advancements in medical science and technology, and the adoption of endovascular repair procedures.
The aortic stent grafts market size is expected to see strong growth in the next few years. It will grow to $4.63 billion in 2028 at a compound annual growth rate (CAGR) of 8.7%. Forecasted growth is expected due to enhanced healthcare infrastructure, favorable reimbursement policies, the transition towards bifurcated abdominal aortic stent grafts, rising popularity of hybrid procedures, and heightened emphasis on training and education for healthcare professionals. Key trends in the forecast period encompass technological advancements, novel product developments, increased regulatory approvals, higher investments in research and development, and improved healthcare infrastructure.
The growth of the aortic stent graft market is driven by the increasing prevalence of cardiovascular diseases. Lifestyle factors such as poor diet, lack of exercise, smoking, and rising obesity rates contribute significantly to the rise in cardiovascular disease cases. Aortic stent grafts are crucial in treating cardiovascular conditions by repairing and reinforcing weakened sections of the aorta, particularly in cases of aneurysms. According to the British Heart Foundation, coronary heart disease (CHD) was a leading cause of mortality in the UK in January 2024, responsible for approximately 68,000 deaths annually, translating to one death roughly every eight minutes. This underscores the significant impact of cardiovascular diseases on driving the growth of the aortic stent graft market.
Leading companies in the aortic stent graft market are focused on advancing their product offerings, such as polymer-based grafts, to improve efficacy and patient outcomes. Polymer-based grafts utilize synthetic materials to replace or reinforce blood vessels or other tubular structures in surgical procedures. For instance, in May 2021, Endologix Inc. launched the Alto abdominal stent graft in Canada, featuring innovative polymer-based technology designed for patients with abdominal aortic aneurysms (AAA). This product includes a low-profile delivery system and a conformable sealing ring that adapts to the patient's aortic neck anatomy during deployment.
In December 2023, Tekni-Plex Inc. strengthened its position in the healthcare sector by acquiring Seisa Medical, a US-based medical device manufacturer specializing in aortic stent grafts and valve components. This acquisition enhanced TekniPlex Healthcare's capabilities in medical materials science and process technologies, particularly in developing minimally invasive and interventional therapy devices.
Major companies operating in the aortic stent grafts market are Cardinal Health Inc., Medtronic plc, Aptus Endosystems Inc., B. Braun Inc., Terumo Corporation, W.L. Gore & Associates Inc., Cook Medical Inc., Getinge AB, Merit Medical Systems Inc., MicroPort Scientific Corporation, Seisa Medical Inc., Artivion Inc., Lifetech Scientific (Shenzhen) Co. Ltd., Endologix Inc., Braile Biomedica, Biomerics LLC, Jotech GmbH, OptiMed Medizinische Instrumente GmbH, Bentley InnoMed GmbH, Endospan Ltd.
North America was the largest region in the aortic stent grafts market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the aortic stent grafts market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the aortic stent grafts market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The aortic stent grafts market consists of sales of tube aortic stent grafts, bifurcated aortic stent grafts, and aorto-uniiliac aortic stent grafts. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Aortic Stent Grafts Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on aortic stent grafts market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for aortic stent grafts ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The aortic stent grafts market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.
The impact of higher inflation in many countries and the resulting spike in interest rates.
The continued but declining impact of COVID-19 on supply chains and consumption patterns.